A detailed history of New York State Common Retirement Fund transactions in Glaukos Corp stock. As of the latest transaction made, New York State Common Retirement Fund holds 393,110 shares of GKOS stock, worth $59.3 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
393,110
Previous 503,018 21.85%
Holding current value
$59.3 Million
Previous $59.5 Million 13.97%
% of portfolio
0.07%
Previous 0.08%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$113.62 - $135.39 $12.5 Million - $14.9 Million
-109,908 Reduced 21.85%
393,110 $51.2 Million
Q2 2024

Jul 31, 2024

SELL
$89.48 - $118.35 $1.05 Million - $1.39 Million
-11,712 Reduced 2.28%
503,018 $59.5 Million
Q1 2024

May 07, 2024

BUY
$76.4 - $96.33 $129,956 - $163,857
1,701 Added 0.33%
514,730 $48.5 Million
Q4 2023

Feb 01, 2024

BUY
$59.53 - $85.11 $111,142 - $158,900
1,867 Added 0.37%
513,029 $40.8 Million
Q3 2023

Nov 07, 2023

BUY
$69.23 - $79.09 $432,618 - $494,233
6,249 Added 1.24%
511,162 $38.5 Million
Q2 2023

Aug 07, 2023

SELL
$45.44 - $71.21 $225,745 - $353,771
-4,968 Reduced 0.97%
504,913 $36 Million
Q1 2023

May 02, 2023

BUY
$43.88 - $52.48 $3.67 Million - $4.39 Million
83,693 Added 19.64%
509,881 $25.5 Million
Q4 2022

Jan 30, 2023

SELL
$40.82 - $57.75 $126,950 - $179,602
-3,110 Reduced 0.72%
426,188 $18.6 Million
Q3 2022

Nov 08, 2022

BUY
$46.84 - $58.49 $89,417 - $111,657
1,909 Added 0.45%
429,298 $22.9 Million
Q2 2022

Aug 04, 2022

BUY
$34.86 - $63.77 $2.59 Million - $4.73 Million
74,201 Added 21.01%
427,389 $19.4 Million
Q1 2022

May 05, 2022

SELL
$44.33 - $57.82 $16,668 - $21,740
-376 Reduced 0.11%
353,188 $20.4 Million
Q4 2021

Feb 02, 2022

SELL
$40.27 - $56.99 $2.07 Million - $2.94 Million
-51,501 Reduced 12.71%
353,564 $15.7 Million
Q3 2021

Nov 02, 2021

SELL
$47.43 - $84.23 $28 Million - $49.7 Million
-590,357 Reduced 59.31%
405,065 $19.5 Million
Q2 2021

Aug 02, 2021

SELL
$73.06 - $97.7 $3.24 Million - $4.33 Million
-44,308 Reduced 4.26%
995,422 $84.4 Million
Q1 2021

May 11, 2021

BUY
$70.43 - $97.42 $284,466 - $393,479
4,039 Added 0.39%
1,039,730 $87.3 Million
Q4 2020

Feb 08, 2021

SELL
$48.9 - $75.26 $100,049 - $153,981
-2,046 Reduced 0.2%
1,035,691 $77.9 Million
Q3 2020

Nov 05, 2020

BUY
$37.23 - $50.97 $8.11 Million - $11.1 Million
217,854 Added 26.57%
1,037,737 $51.4 Million
Q2 2020

Aug 07, 2020

BUY
$28.78 - $46.83 $103,608 - $168,588
3,600 Added 0.44%
819,883 $31.5 Million
Q1 2020

May 06, 2020

SELL
$25.53 - $70.14 $290,556 - $798,263
-11,381 Reduced 1.38%
816,283 $25.2 Million
Q4 2019

Feb 05, 2020

BUY
$54.18 - $65.64 $435,336 - $527,417
8,035 Added 0.98%
827,664 $45.1 Million
Q3 2019

Nov 07, 2019

BUY
$58.58 - $83.91 $15.9 Million - $22.8 Million
271,643 Added 49.57%
819,629 $51.2 Million
Q2 2019

Aug 09, 2019

BUY
$63.59 - $78.71 $2.3 Million - $2.84 Million
36,128 Added 7.06%
547,986 $41.3 Million
Q1 2019

May 08, 2019

BUY
$50.75 - $80.54 $71,050 - $112,756
1,400 Added 0.27%
511,858 $40.1 Million
Q4 2018

Feb 08, 2019

BUY
$52.18 - $67.93 $15.5 Million - $20.2 Million
297,158 Added 139.31%
510,458 $28.7 Million
Q3 2018

Nov 07, 2018

BUY
$38.13 - $68.37 $2.3 Million - $4.13 Million
60,362 Added 39.47%
213,300 $13.8 Million
Q2 2018

Aug 10, 2018

BUY
$27.62 - $44.51 $168,482 - $271,511
6,100 Added 4.15%
152,938 $6.22 Million
Q1 2018

May 10, 2018

BUY
$26.05 - $34.5 $740,132 - $980,214
28,412 Added 23.99%
146,838 $4.53 Million
Q4 2017

Feb 13, 2018

SELL
$24.5 - $36.01 $575,676 - $846,126
-23,497 Reduced 16.56%
118,426 $3.04 Million
Q3 2017

Nov 06, 2017

BUY
$31.26 - $42.03 $885,595 - $1.19 Million
28,330 Added 24.94%
141,923 $4.68 Million
Q2 2017

Aug 11, 2017

BUY
N/A
113,593
113,593 $4.71 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.18B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.